Steele, M. M. & Lund, A. W. Afferent lymphatic transport and peripheral tissue. J. Immunol. 206, 264–272 (2021).
Article CAS PubMed Google Scholar
Lund, A. W. et al. Lymphatic vessels regulate immune microenvironments in human and mouse melanoma. J. Clin. Invest. 126, 3389–3402 (2016).
Article PubMed PubMed Central Google Scholar
Loo, C. P. et al. Lymphatic vessels balance viral dissemination and immune activation following cutaneous viral infection. Cell Rep. 20, 3176–3187 (2017).
Article CAS PubMed PubMed Central Google Scholar
Alitalo, A. K. et al. VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. Cancer Res. 73, 4212–4221 (2013).
Article CAS PubMed Google Scholar
Lund, A. W. et al. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 1, 191–199 (2012).
Article CAS PubMed Google Scholar
Gkountidi, A. O. et al. MHC class II antigen presentation by lymphatic endothelial cells in tumors promotes intratumoral regulatory T cell-suppressive functions. Cancer Immunol. Res. 9, 748–764 (2021).
Article CAS PubMed Google Scholar
Garnier, L. et al. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci. Adv. 8, eabl5162 (2022).
Article CAS PubMed PubMed Central Google Scholar
Lane, R. S. et al. IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. J. Exp. Med. 215, 3057–3074 (2018).
Article CAS PubMed PubMed Central Google Scholar
Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74–80 (2015).
Article CAS PubMed Google Scholar
Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575–579 (2018).
Article CAS PubMed Google Scholar
Khan, T. N., Mooster, J. L., Kilgore, A. M., Osborn, J. F. & Nolz, J. C. Local antigen in nonlymphoid tissue promotes resident memory CD8+ T cell formation during viral infection. J. Exp. Med. 213, 951–966 (2016).
Article CAS PubMed PubMed Central Google Scholar
Mackay, C. R., Kimpton, W. G., Brandon, M. R. & Cahill, R. N. Lymphocyte subsets show marked differences in their distribution between blood and the afferent and efferent lymph of peripheral lymph nodes. J. Exp. Med. 167, 1755–1765 (1988).
Article CAS PubMed Google Scholar
Olszewski, W. L., Grzelak, I., Ziolkowska, A. & Engeset, A. Immune cell traffic from blood through the normal human skin to lymphatics. Clin. Dermatol. 13, 473–483 (1995).
Article CAS PubMed Google Scholar
Tomura, M. et al. Monitoring cellular movement in vivo with photoconvertible fluorescence protein ‘Kaede’ transgenic mice. Proc. Natl Acad. Sci. USA 105, 10871–10876 (2008).
Article CAS PubMed PubMed Central Google Scholar
Steele, M. et al. Quantifying leukocyte egress from mouse skin and tumors. J. Vis. Exp. 143, 58704 (2019).
Torcellan, T. et al. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc. Natl Acad. Sci. 114, 5677–5682 (2017).
Article CAS PubMed PubMed Central Google Scholar
Li, Z. et al. In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue. J. Exp. Med. 219, e20210749 (2022).
Article CAS PubMed PubMed Central Google Scholar
Brown, M. N. et al. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J. Immunol. 185, 4873–4882 (2010).
Article CAS PubMed Google Scholar
Mäkinen, T. et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7, 199–205 (2001).
Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029–1045 (2018).
Article CAS PubMed PubMed Central Google Scholar
Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity 45, 415–427 (2016).
Article CAS PubMed Google Scholar
Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195–211 (2019).
Article CAS PubMed Google Scholar
Schneider, O. D., Weiss, A. A. & Miller, W. E. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J. Immunol. 182, 5730–5739 (2009).
Article CAS PubMed Google Scholar
Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9, 883–897 (2010).
Article CAS PubMed Google Scholar
Skon, C. N. et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat. Immunol. 14, 1285–1293 (2013).
Article CAS PubMed PubMed Central Google Scholar
Kabashima, K. et al. CXCL12–CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171, 1249–1257 (2007).
Article CAS PubMed PubMed Central Google Scholar
Schmidt, T. H., Bannard, O., Gray, E. E. & Cyster, J. G. CXCR4 promotes B cell egress from Peyer’s patches. J. Exp. Med. 210, 1099–1107 (2013).
Article CAS PubMed PubMed Central Google Scholar
Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212–20217 (2013).
Article CAS PubMed PubMed Central Google Scholar
Di Pilato, M. et al. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell 184, 4512–4530 (2021).
Article PubMed PubMed Central Google Scholar
Wein, A. N. et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J. Exp. Med. 216, 2748–2762 (2019).
Article CAS PubMed PubMed Central Google Scholar
Mackay, L. K. et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294–1301 (2013).
Article CAS PubMed Google Scholar
Schietinger, A. et al. Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis. Immunity 45, 389–401 (2016).
Article CAS PubMed PubMed Central Google Scholar
Berkley, A. M. & Fink, P. J. Cutting edge: CD8+ recent thymic emigrants exhibit increased responses to low-affinity ligands and improved access to peripheral sites of inflammation. J. Immunol. 193, 3262–3266 (2014).
Article CAS PubMed Google Scholar
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998–1013 (2018).
Article CAS PubMed PubMed Central Google Scholar
Jaiswal, A. et al. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. Cancer Cell 40, 524–544 (2022).
Article CAS PubMed Google Scholar
Dankort, D. et al. BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 41, 544–552 (2009).
留言 (0)